sglt2 inhibitors and glp 1 receptor agonists Effect of combination treatment with glucagon-like peptide-1 sodium-glucose cotransporter-2 on incidence of cardiovascular and serious renal events: population based cohort study SGLT-2 inhibitors and GLP-1 receptor
Description
Age-dependent human beta cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling
Side effects are generally mild and manageable, usually involving only mild gastrointestinal symptoms that resolve quickly
Our results showed that allulose mitigated the adverse effects of high-fat, high-sugar diets, including reduced body weight gain and improved insulin resistance
Endres LK, Straub H, McKinney C, Plunkett B, Minkovitz CS, Schetter CD, et al
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression
